|
Volcano Corporation Presentation at Bank of America/Merrill Lynch Conference to be Webcast
|
 |
 |
|
May 6, 2009 -- San Diego --
Volcano Corporation (Nasdaq: VOLC), a leader in the development,
manufacturing and sales of products for the diagnosis and treatment
of coronary and peripheral artery disease, said today that it
will be participating in the Bank of America and Merrill Lynch
2009 Health Care Conference on Thursday, May 14. |
The presentation by Scott Huennekens, president and chief executive officer, will begin at 11:20 a.m., Eastern Daylight Time (8:20 a.m., Pacific Daylight Time).
The presentation will be available through the conference website at http://www.veracast.com/webcasts/bas/healthcare09/id83306132.cfm and via the company's website at www.volcanocorp.com.
Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also provides Functional Measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters. Currently, more than 4,200 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. For more information, visit the company's website at www.volcanocorp.com.
Source: Volcano
Corporation
|
